Austar Lifesciences Limited (6118.HK)
- Previous Close
0.890 - Open
0.900 - Bid 0.810 x --
- Ask 0.820 x --
- Day's Range
0.810 - 0.900 - 52 Week Range
0.810 - 3.180 - Volume
526,000 - Avg. Volume
456,616 - Market Cap (intraday)
420.317M - Beta (5Y Monthly) 1.07
- PE Ratio (TTM)
-- - EPS (TTM)
-0.060 - Earnings Date Mar 27, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date May 19, 2015
- 1y Target Est
--
Austar Lifesciences Limited, an investment holding company, engages in the provision of integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally. It operates through six segments: Liquid and Bioprocess System; Clean Room and Automation Control and Monitoring System; Powder and Solid System; GMP Compliance Service; Life Science Consumables; and Distribution and Agency of Pharmaceutical Equipment. The company offers liquid and bioprocess systems, including pharmaceutical water, and liquid preparation and bioprocess systems; clean room enclosure, automation control and monitoring systems; and freeze-dryer, sterile filling, and visual inspection equipment, as well as clean utility, powder, and solid equipment and systems. It also provides pharmaceutical process contamination control products; packaging and aseptic containment products; biosafety and lab animal equipment and consumables; laboratory one-stop solutions; and single-use bioprocess equipment and consumables. In addition, the company offers pharmaceutical engineering design, consulting, process technology, facility operations and maintenance, laboratory and digitalization construction, quality risk control, and research and development services. Further, it is involved in the agency and distribution of pharmaceutical equipment, as well as provides contract execution, assembly and pre-assembly, and GMP compliance services. The company was founded in 1991 and is headquartered in Shanghai, China.
www.austar.com.hkRelated News
Performance Overview: 6118.HK
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 6118.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 6118.HK
Valuation Measures
Market Cap
420.32M
Enterprise Value
768.76M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.22
Price/Book (mrq)
0.50
Enterprise Value/Revenue
0.44
Enterprise Value/EBITDA
-37.59
Financial Highlights
Profitability and Income Statement
Profit Margin
-6.43%
Return on Assets (ttm)
-1.00%
Return on Equity (ttm)
-4.19%
Revenue (ttm)
1.76B
Net Income Avi to Common (ttm)
-32.61M
Diluted EPS (ttm)
-0.060
Balance Sheet and Cash Flow
Total Cash (mrq)
173.76M
Total Debt/Equity (mrq)
63.99%
Levered Free Cash Flow (ttm)
--
Company Insights: 6118.HK
6118.HK does not have Company Insights